TERT and cancer: While −124 mutants are known to have a mutation that recruits ETS transcription factors such as GABP to activate TERT expression [10], still approximately 78% of cancer cell lines have wild‐type TERT promoters and do not contain known activating cis‐acting genetic alterations [9].